Rotation Medical Inc presented results from its REBUILD (Rotation MEdical BioindUctive ImpLant Database) registry of its Bioconductive Implant recently at the Arthroscopy Association of North America Annual Meeting.
The REBUILD registry is designed to collect patient-reported outcomes, including shoulder function, pain, and quality of life, after receiving the Bioconductive Implant as a treatment for rotator cuff injury.
Interim results of the first 200 patients showed significantly less postoperative pain and use of narcotics, less sling time, faster return to function, and better overall shoulder rating, according to a media release from Rotation Medical Inc.
In addition, per the release, patients in the REBUILD registry report feeling better 6 months after receiving the Bioinductive Implant than those who received standard treatment did at 2 years.
“Patients often opt out or delay surgery in the early stages of rotator cuff disease due to long and painful rehabilitation,” says Dr Louis McIntyre, study investigator and orthopedic surgeon at Northwell Health Physician Partners Orthopaedic Institute at Sleepy Hollow, New York.
“Initial results of the REBUILD registry demonstrate statistically significant improvements in several outcomes measures, including pain, function, and overall shoulder rating,” he adds, in the release.
In total, up to 300 patients will be followed across 20 study centers. The data collected in the registry will then be compared to data in a national orthopaedic database using standard rotator cuff treatment.
“With the results of the REBUILD registry, we believe our Bioinductive Implant is well-positioned to transform the treatment of rotator cuff disease, enabling patients to get back to work and other activities more quickly with less pain and use of narcotics than traditional rotator cuff repair,” explains Martha Shadan, president and CEO of Rotation Medical, in the release.
[Source(s): Rotation Medical Inc, Business Wire]